Please assess the completion status of the following clinical trial:

Trial Title: GORE EXCLUDER® Endoprosthesis - Low Permeability in Treatment of Abdominal Aortic Aneurysms

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. Infrarenal Abdominal Aortic Aneurysms less than 4.5 cm in diameter~2. Anatomy meets EXCLUDER Bifurcated Endoprosthesis - Low Permeability specification criteria per Instructions for Use~3. Access vessel able to receive 18 French introducer sheath~4. Life expectancy \> 2 years~5. Appropriate candidate for endovascular repair~6. Ability to comply with protocol requirements including follow-up~7. 21 years of age or older, male or infertile female\*\*~Exclusion Criteria:~1. Mycotic or ruptured aneurysm~2. Participating in another investigational device or drug study within one year~3. Documented history of drug abuse within six months~4. Myocardial infarction or cerebral vascular accident within six weeks~5. Pulmonary insufficiency requiring chronic home oxygen or inability to ambulate due to pulmonary function~6. Iliac anatomy that would require occlusion of both internal iliac arteries~7. Planned occlusion or reimplantation of significant mesenteric or renal arteries~8. Planned concomitant surgical procedure or previous major surgery within 30 days~9. Previous prosthesis placement in the aorta or iliac arteries~10. Degenerative connective tissue disease (e.g., Marfan's and Ehlers Danlos Syndrome)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).